Pfs Investments Inc. Natera, Inc. Transaction History

Pfs Investments Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$30.32 - $91.33 $708,153 - $2.13 Million	-23,356 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$86.26 - $119.0 $356,253 - $491,470	4,130 Added 21.48%	23,356 $2.18 Million
Q3 2021 Nov 15, 2021	SELL	$100.17 - $126.36 $377,841 - $476,629	-3,772 Reduced 16.4%	19,226 $2.25 Million
Q2 2021 Aug 13, 2021	BUY	$86.05 - $119.72 $1.32 Million - $1.84 Million	15,365 Added 201.3%	22,998 $2.78 Million
Q1 2021 May 17, 2021	BUY	$91.47 - $124.36 $698,190 - $949,239	7,633 New	7,633 $775,000

527

118M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $15.7B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Pfs Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Pfs Investments Inc. with notifications on news.